Raia Drogasil S.A.
RADLY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $30,969 | $24,504 | $34,686 | $33,220 |
| - Cash | $436 | $527 | $404 | $528 |
| + Debt | $8,148 | $8,421 | $7,718 | $7,695 |
| Enterprise Value | $38,680 | $32,398 | $42,000 | $40,387 |
| Revenue | $11,265 | $10,831 | $10,051 | $10,088 |
| % Growth | 4% | 7.8% | -0.4% | – |
| Gross Profit | $2,807 | $3,201 | $2,883 | $2,988 |
| % Margin | 24.9% | 29.6% | 28.7% | 29.6% |
| EBITDA | $1,325 | $1,183 | $915 | $11 |
| % Margin | 11.8% | 10.9% | 9.1% | 0.1% |
| Net Income | $454 | $374 | $164 | $348 |
| % Margin | 4% | 3.5% | 1.6% | 3.5% |
| EPS Diluted | 0.27 | 0.23 | 0.099 | 0.21 |
| % Growth | 17.4% | 132.1% | -52.8% | – |
| Operating Cash Flow | $995 | $496 | $521 | $228 |
| Capital Expenditures | -$378 | -$323 | -$271 | -$431 |
| Free Cash Flow | $617 | $173 | $251 | -$204 |